Premium Stock Alerts

[Drugdoctor]

Thanks for asking, since it took about 9 months from the time of filing the ANDA for hydromorphone to be approved for ELTP and the naltrexone and the phendimetazine ANDA requests, and the fact that it has been about 10 months now for ELTP, and the CEO just told us that the final inspections by the FDA have been COMPLETED, I'm basing it on that timeframe. He also said he expected several new products to be on the market by the end of 2012. So, with that said, we are expecting approvals anytime from next week to the end of the year. 2 of the drugs are known to us, and 2 of the drugs are unknown, but still subject to pass FDA review at any time.

At the time approval hits, the stock will probably surge, so getting in at 4 month lows now, is probably a "safe" entry. However, I'm in ELTP long term, the day to day fluctation isn't important unless I am adding to my position, as I expect this stock to eventually trade back up into the dollars.

There are also new products that we don't even know about for competitive reasons, that are being developed secretly based on the recent patent approval that ELTP obtained.

GLTA

http://www.elitepharma.com/product_pipeline.asp